- Previous Close
2.9900 - Open
2.9600 - Bid 2.9600 x --
- Ask 2.9700 x --
- Day's Range
2.9600 - 2.9700 - 52 Week Range
1.8000 - 4.3500 - Volume
620 - Avg. Volume
28,998 - Market Cap (intraday)
45.089M - Beta (5Y Monthly) 0.76
- PE Ratio (TTM)
27.00 - EPS (TTM)
0.1100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Apr 15, 2014
- 1y Target Est
3.20
Biohit Oyj, a biotechnology company, manufactures and sells bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry worldwide. The company's diagnostic tests product includes the GastroPanel Unified test panel for stomach health check; GastroPanel Four-in-One stomach test; GastroSoft software application to assist clinicians and general practitioner; Biohit Active B12, a test for measuring the levels of active vitamin B12; BIOHIT Total 25OH Vitamin D, a test for determination of vitamin D status; and Biohit Calprotectin test for measuring human calprotectin. It also offers GastroPanel quick test NT, a quantitative immunochromatographic test for the detection of Helicobacter pylori (H. Pylori) and atrophic gastritis; BIOHIT Celiac Quick test for diagnosis of celiac disease; Biohit ColonView Quick test, a test for detection of fecal occult blood; Biohit Helicobacter Pylori UFT300 and Helicobacter Pylori Quick test methods to detect H. pylori infection; and Lactose Intolerance quick test to support the diagnosis of lactose intolerance in a duodenal biopsy specimen. In addition, the company provides acetaldehyde-binding products, such as Acetium capsules that are intended for persons with a low-acid or anacidic stomach; and Acetium lozenge, which helps in quitting smoking; and monoclonal antibodies for use in the areas of cellular pathology, neurobiology, oncology, and human gastric biomarkers research. The company was incorporated in 1988 and is headquartered in Helsinki, Finland.
www.biohithealthcare.comRecent News: BIOBV.HE
View MorePerformance Overview: BIOBV.HE
Trailing total returns as of 1/31/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BIOBV.HE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BIOBV.HE
View MoreValuation Measures
Market Cap
45.39M
Enterprise Value
41.09M
Trailing P/E
27.18
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.24
Price/Book (mrq)
4.20
Enterprise Value/Revenue
2.94
Enterprise Value/EBITDA
22.73
Financial Highlights
Profitability and Income Statement
Profit Margin
11.81%
Return on Assets (ttm)
8.08%
Return on Equity (ttm)
16.68%
Revenue (ttm)
13.98M
Net Income Avi to Common (ttm)
1.65M
Diluted EPS (ttm)
0.1100
Balance Sheet and Cash Flow
Total Cash (mrq)
5M
Total Debt/Equity (mrq)
6.48%
Levered Free Cash Flow (ttm)
-796.88k